Case Study: Litigation support
The Challenge
An established US biotechnology company and a US-based biopharmaceutical company were in litigation over the validity of a licensed patent (and associated product royalty payments) covering a core biopharmaceutical manufacturing technology. PharmaVentures supported the law firm representing the established biotechnology company with its in-depth knowledge and expertise.
The Solution
Using PharmaVentures' extensive industry insight and experience on transactions of intellectual property, Dr Fintan Walton, CEO of PharmaVentures, provided a concise, substantiated expert report on secondary considerations of non-obviousness followed by an oral deposition. This led to an early settlement on terms that were very favourable to our client.